4//SEC Filing
Shabahang Shahrokh 4
Accession 0001213900-21-030054
CIK 0001726711other
Filed
May 27, 8:00 PM ET
Accepted
May 28, 6:49 PM ET
Size
8.3 KB
Accession
0001213900-21-030054
Insider Transaction Report
Form 4
Shabahang Shahrokh
DirectorCHIEF INNOVATION OFFICER
Transactions
- Purchase
Common Stock
2021-05-27$2.70/sh+185$500→ 1,015,608 total - Purchase
Common Stock
2021-05-25$2.40/sh+279$670→ 1,015,285 total(indirect: By son) - Purchase
Common Stock
2021-05-25$2.38/sh+138$328→ 1,015,423 total(indirect: By son)
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F2]Fractional amounts have been rounded to the nearest whole number.
Documents
Issuer
Aditx Therapeutics, Inc.
CIK 0001726711
Entity typeother
Related Parties
1- filerCIK 0001816754
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 6:49 PM ET
- Size
- 8.3 KB